Cartilage derived morphogenetic protein 2 - a potential therapy for intervertebral disc regeneration?

Lisa A Williams1, Aiqun Wei1, Divya Bhargav1

  • 1Department of Orthopaedic Research, Orthopaedic Research Institute, St George Hospital, University of New South Wales, Sydney, Australia.

Summary

Low back pain is a leading cause of disability. Cartilage derived morphogenetic protein-2 (CDMP2) shows promise for early intervention in intervertebral disc degeneration, potentially preserving spinal function.